Cite
Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients.
MLA
Martino, Massimo, et al. “Low Tolerance and High Toxicity of Thalidomide as Maintenance Therapy after Double Autologous Stem Cell Transplant in Multiple Myeloma Patients.” European Journal of Haematology, vol. 78, no. 1, Jan. 2007, pp. 35–40. EBSCOhost, https://doi.org/10.1111/j.1600-0609.2006.00774.x.
APA
Martino, M., Console, G., Callea, V., Stelitano, C., Massara, E., Irrera, G., Messina, G., Morabito, F., & Iacopino, P. (2007). Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients. European Journal of Haematology, 78(1), 35–40. https://doi.org/10.1111/j.1600-0609.2006.00774.x
Chicago
Martino, Massimo, Giuseppe Console, Vincenzo Callea, Caterina Stelitano, Elisabetta Massara, Giuseppe Irrera, Giuseppe Messina, Fortunato Morabito, and Pasquale Iacopino. 2007. “Low Tolerance and High Toxicity of Thalidomide as Maintenance Therapy after Double Autologous Stem Cell Transplant in Multiple Myeloma Patients.” European Journal of Haematology 78 (1): 35–40. doi:10.1111/j.1600-0609.2006.00774.x.